Circassia Pharmaceuticals Plc Total Voting Rights (1040J)
March 29 2018 - 1:00AM
UK Regulatory
TIDMCIR
RNS Number : 1040J
Circassia Pharmaceuticals Plc
29 March 2018
For immediate release
Circassia Pharmaceuticals plc
Total Voting Rights Update
29(th) March 2018
In accordance with the requirements of the FCA's Disclosure and
Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia"
or "the Company") (LSE: CIR) confirms that the Company's issued
share capital consists of 333,466,262 ordinary shares of 0.08p each
in issue, each with equal voting rights. No shares are held in
treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine whether they are
required to notify their interest, or a change to their interest,
in the Company under the FCA's Disclosure and Transparency
Rules.
-Ends-
For further information, please contact:
Circassia Pharmaceuticals plc +44 (0) 1865
Julien Cotta, Company Secretary 405560
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVREAFDXALXPEFF
(END) Dow Jones Newswires
March 29, 2018 02:00 ET (06:00 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Circassia Group Plc (London Stock Exchange): 0 recent articles
More Circassia Pharmaceuticals News Articles